Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers
Sign Up to like & getrecommendations! Published in 2017 at "Journal Of The National Cancer Institute"
DOI: 10.1093/jnci/djw262
Abstract: Inhibitors of the receptor tyrosine kinase (RTK) MET have been ineffective at treating cancer, possibly because of lack of knowledge that would allow selection of tumors likely to respond to this treatment. In contrast, specific… read more here.
Keywords: biomarker target; exon deleted; new biomarker; deleted met ... See more keywords
Substance P and neurokinin 1 receptor are new targets for the treatment of chronic pruritus
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Dermatology"
DOI: 10.1111/bjd.18025
Abstract: Chronic pruritus is a distressing symptom associated with various dermatological conditions and systemic diseases. Current treatment options are often inadequate, resulting in impaired quality of life for many patients. An understanding of the underlying mechanisms… read more here.
Keywords: neurokinin receptor; substance neurokinin; receptor new; treatment ... See more keywords
GLP-1 Receptor: A New Target for Sepsis
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2021.706908
Abstract: Patients with sepsis often exhibit hyperglycemia, which increases mortality. glucagon-like peptide-1 receptor agonists (GLP-1RAs) not only regulate blood glucose homeostasis but also improve organ dysfunction, regulate immunity, and control inflammation and other functions in patients… read more here.
Keywords: sepsis; receptor new; new target; target sepsis ... See more keywords